Article

Genome scale identification of Treponema pallidum antigens

Department of Molecular Virology and Microbiology, Baylor College of Medicine, One Baylor Plaza, Houston, Texas 77030, USA.
Infection and Immunity (Impact Factor: 4.16). 08/2005; 73(7):4445-50. DOI: 10.1128/IAI.73.7.4445-4450.2005
Source: PubMed

ABSTRACT Antibody responses for 882 of the 1,039 proteins in the proteome of Treponema pallidum were examined. Sera collected from infected rabbits were used to systematically identify 106 antigenic proteins, including 22 previously identified antigens and 84 novel antigens. Additionally, sera collected from rabbits throughout the course of infection demonstrated a progression in the breadth and intensity of humoral immunoreactivity against a representative panel of T. pallidum antigens. Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Download full-text

Full-text

Available from: Steven J Norris, Aug 14, 2015
0 Followers
 · 
139 Views
  • Source
    • "Similar variability in the number of invariant repetitions was found in the TP0470 gene (Mikalová et al., 2010; Strouhal et al., 2007). Moreover, the conserved hypothetical protein TP0470 was found to be immunogenic (Brinkman et al., 2006; McKevitt et al., 2005). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Pathogenic uncultivable treponemes, similar to syphilis-causing Treponema pallidum subspecies pallidum, include T. pallidum ssp. pertenue, T. pallidum ssp. endemicum and Treponema carateum, which cause yaws, bejel and pinta, respectively. Genetic analyses of these pathogens revealed striking similarity among these bacteria and also a high degree of similarity to the rabbit pathogen, Treponema paraluiscuniculi, a treponeme not infectious to humans. Genome comparisons between pallidum and non-pallidum treponemes revealed genes with potential involvement in human infectivity, whereas comparisons between pallidum and pertenue treponemes identified genes possibly involved in the high invasivity of syphilis treponemes. Genetic variability within syphilis strains is considered as the basis of syphilis molecular epidemiology with potential to detect more virulent strains, whereas genetic variability within a single strain is related to its ability to elude the immune system of the host. Genome analyses also shed light on treponemal evolution and on chromosomal targets for molecular diagnostics of treponemal infections.
    Infection, genetics and evolution: journal of molecular epidemiology and evolutionary genetics in infectious diseases 12/2011; 12(2):191-202. DOI:10.1016/j.meegid.2011.12.001 · 3.26 Impact Factor
  • Source
    • "With protein arrays, the limitation is based on the yield of the lowest expressed protein and quantities are always finite. Nonetheless , partial protein arrays have been developed for a few bacteria including Yersinia pestis [26], Treponema pallidum [27], and Chlamydia trachomatis [28]. Once constructed, protein arrays are very powerful tools that enable the direct comparison of unknown proteins with known antigens across an even platform. "
    [Show abstract] [Hide abstract]
    ABSTRACT: As an initial step toward systematically characterizing all antigenic proteins produced by a significant veterinary pathogen, 43 recombinant Mycobacterium avium subspecies paratuberculosis (M. paratuberculosis) expression clones were constructed, cataloged, and stored. NC filters were spotted with purified proteins from each clone along with a whole cell lysate of M. paratuberculosis. Spots on the resulting dot array consisted of hypothetical proteins (13), metabolic proteins (3), cell envelope proteins (7), known antigens (4), and unique proteins with no similarity in public sequence databases (16). Dot blot arrays were used to profile antibody responses in a rabbit and mouse exposed to M. paratuberculosis as well as in cattle showing clinical signs of Johne's disease. The M. paratuberculosis heat shock protein DnaK, encoded by ORF MAP3840 and a membrane protein (MAP2121c), were identified as the most strongly immunoreactive in both the mouse and rabbit hosts, respectively. MAP3155c, which encodes a hypothetical protein, was most strongly immunoreactive in sera from Johne's disease cattle. This study has enabled direct comparisons of antibody reactivity for an entire panel of over 40 proteins and has laid the foundation for future high throughput production and arraying of M. paratuberculosis surface proteins for immune profiling experiments in cattle.
    PROTEOMICS 02/2008; 8(3):463-74. DOI:10.1002/pmic.200700644 · 3.97 Impact Factor
  • Source
    • "antigenic proteins in detail (Hendrickson et al., 2000; McKevitt et al., 2005; Kowalczewska et al., 2006). However, the analysis of the proteome of an uncultivable bacterium such as M. suis recovered directly from the intact host causes serious technical challenges for the investigator, mainly because of the low recovery of bacterial cells from the host as well as the necessity of maximum purification of the bacterial cells from host tissue residues. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The antigenic structures of the haemotrophic Mycoplasma suis, an epicellular parasite of porcine erythrocytes, are largely unknown due to its unculturability. In this study, serological proteome and mass spectrometry analyses allowed the characterization of M. suis proteins targeted by the porcine antibody response: two proteins with characteristics of heat shock proteins, two proteins with characteristics of glycolytic enzymes, a RNA helicase- and an actin-like protein. The DnaK-like protein of M. suis (HspA1) was further analysed genetically and functionally. Its encoding gene (M. suis a1 gene) is 1.830 bp in size and corresponds to a 67 kDa protein. Immunoelectron microscopy verified the surface accessibility of HspA1 in M. suis. Recombinant HspA1 expressed in Escherichia coli demonstrated ATPase activity and antigenicity in experimentally infected pigs. In conclusion, this first identification and recombinant expression of an antigenic protein of M. suis provides the basis for the development of vaccines and new in vitro diagnostic assays.
    FEMS Immunology & Medical Microbiology 04/2007; 49(2):215-23. DOI:10.1111/j.1574-695X.2006.00184.x · 2.55 Impact Factor
Show more